Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts.  Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group.  He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.  

Dr Emmanouil Karteris is a Senior Lecturer at Brunel University London and Head of Cancer Biomarkers and Cellular Endocrinology Lab (www.cbcel.org). He gained his BSc degree in Medical Biochemistry (University of Surrey, 1995), MSc in Medical Genetics with Immunology (Brunel University 1996) and his PhD (Warwick University, 2000). Dr Karteris has published 72 research manuscripts (h-index: 26; i10-index:50) and has presented over 100 abstracts in leading international conferences. He also has expertise Intellectual Property (IP) law and in setting up clinical studies. His lab focuses in the characterisation and enumeration of circulating tumour cells using bioimaging techniques, as well as bioinformatic analyses using RNA-seq and measurements of circulating free DNA (cfDNA) and circulating tumour DNA (ctDNA) from liquid biopsies from a wide repertoire of tumours. His lab also investigates the role of endocrine disruptors in health and disease.